Impaired Placentation in Fetal Alcohol Syndrome

Placenta

Volumn 29, Issue 2, 2008, Pages 148-157

  Gundogan, F ^a,c   Elwood, G ^b   Longato, L ^b   Tong, M ^b,c   Feijoo, A ^b   Carlson, R I ^b   Wands, J R ^b,c   de la Monte, S M ^a,b,c  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Aspartyl (asparaginyl) hydroxylase; Fetal alcohol syndrome; Insulin like growth factor; Placenta; Placentation

Indexed keywords

ALCOHOL; ASPARTYLASPARAGINYL BETA HYDROXYLASE; MESSENGER RNA; OXYGENASE; SOMATOMEDIN; UNCLASSIFIED DRUG;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL ALCOHOL SYNDROME; GESTATION PERIOD; HISTOPATHOLOGY; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; LONG EVANS RAT; LONG TERM EXPOSURE; NONHUMAN; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TROPHOBLAST; UTERINE BLOOD VESSEL; WESTERN BLOTTING;

ANIMALS; ETHANOL; FEMALE; FETAL ALCOHOL SYNDROME; GENE EXPRESSION REGULATION; GESTATIONAL AGE; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MIXED FUNCTION OXYGENASES; PLACENTA; PLACENTA DISEASES; PLACENTATION; PREGNANCY; RATS; RATS, LONG-EVANS; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; TIME FACTORS;

EID: 38649114378     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2007.10.002     Document Type: Article

References (38)

1. Barr H.M., and Streissguth A.P. Identifying maternal self-reported alcohol use associated with fetal alcohol spectrum disorders. Alcohol Clin Exp Res 25 2 (2001) 283-287
2. de la Monte S.M., Xu X.J., and Wands J.R. Ethanol inhibits insulin expression and actions in the developing brain. Cell Mol Life Sci 62 10 (2005) 1131-1145
3. Soscia S.J., Tong M., Xu X.J., Cohen A.C., Chu J., Wands J.R., et al. Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain. Cell Mol Life Sci 63 17 (2006) 2039-2056
4. O'Leary C.M. Fetal alcohol syndrome: diagnosis, epidemiology, and developmental outcomes. J Paediatr Child Health 40 1-2 (2004) 2-7
5. Cornelius M.D., Goldshmidt L., Taylor P.M., and Day N.L. Prenatal alcohol use among teenagers: effects on neonatal outcomes. Alcohol Clin Exp Res 23 7 (1999) 1238-1244
6. Bada H.S., Das A., Bauer C.R., Shankaran S., Lester B.M., Gard C.C., et al. Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol 25 10 (2005) 631-637
7. Kaminski M., Rumeau C., and Schwartz D. Alcohol consumption in pregnant women and the outcome of pregnancy. Alcohol Clin Exp Res 2 2 (1978) 155-163
8. DeChiara T.M., Efstratiadis A., and Robertson E.J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345 6270 (1990) 78-80
9. Laviola L., Perrini S., Belsanti G., Natalicchio A., Montrone C., Leonardini A., et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology 146 3 (2005) 1498-1505
10. Han V.K., and Carter A.M. Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 21 4 (2000) 289-305
11. Jia S., VanDusen W.J., Diehl R.E., Kohl N.E., Dixon R.A., Elliston K.O., et al. cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylase. J Biol Chem 267 20 (1992) 14322-14327
12. Christiansen J.H., Coles E.G., and Wilkinson D.G. Molecular control of neural crest formation, migration and differentiation. Curr Opin Cell Biol 12 6 (2000) 719-724
13. Cotter D., Honavar M., Lovestone S., Raymond L., Kerwin R., Anderton B., et al. Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex. Acta Neuropathol (Berl) 98 5 (1999) 465-472
14. Small D., Kovalenko D., Kacer D., Liaw L., Landriscina M., Di Serio C., et al. Soluble Jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like phenotype. J Biol Chem 276 34 (2001) 32022-32030
15. Lavaissiere L., Jia S., Nishiyama M., de la Monte S., Stern A.M., Wands J.R., et al. Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest 98 6 (1996) 1313-1323
16. Ince N., de la Monte S.M., and Wands J.R. Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation. Cancer Res 60 5 (2000) 1261-1266
17. de la Monte S.M., Tamaki S., Cantarini M.C., Ince N., Wiedmann M., Carter J.J., et al. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. J Hepatol 44 5 (2006) 971-983
18. Sepe P.S., Lahousse S.A., Gemelli B., Chang H., Maeda T., Wands J.R., et al. Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility. Lab Invest 82 7 (2002) 881-891
19. Maeda T., Sepe P., Lahousse S., Tamaki S., Enjoji M., Wands J.R., et al. Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells. J Hepatol 38 5 (2003) 615-622
20. Cantarini M.C., de la Monte S.M., Pang M., Tong M., D'Errico A., Trevisani F., et al. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology 44 2 (2006) 446-457
21. Gundogan F., Elwood G., Greco D., Rubin L.P., Pinar H., Carlson R.I., et al. Role of aspartyl-(asparaginyl) beta-hydroxylase in placental implantation: relevance to early pregnancy loss. Hum Pathol 38 1 (2007) 50-59
22. Xu J., Yeon J.E., Chang H., Tison G., Chen G.J., Wands J., et al. Ethanol impairs insulin-stimulated neuronal survival in the developing brain: role of PTEN phosphatase. J Biol Chem 278 29 (2003) 26929-26937
23. Urso T., Gavaler J.S., and Van Thiel D.H. Blood ethanol levels in sober alcohol users seen in an emergency room. Life Sci 28 9 (1981) 1053-1056
24. Maeda T., Taguchi K., Aishima S., Shimada M., Hintz D., Larusso N., et al. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma. Cancer Detect Prev 28 5 (2004) 313-318
25. Yeon J.E., Califano S., Xu J., Wands J.R., and de La Monte S.M. Potential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver. Hepatology 38 3 (2003) 703-714
26. Takahashi H., Ozturk M., Wilson B., Maki A., Ozawa K., Koizumi M., et al. In vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinoma. Hepatology 9 4 (1989) 625-634
27. Wilson B., Ozturk M., Takahashi H., Motte P., Kew M., Isselbacher K.J., et al. Cell-surface changes associated with transformation of human hepatocytes to the malignant phenotype. Proc Natl Acad Sci U S A 85 9 (1988) 3140-3144
28. Giovannone B., Scaldaferri M.L., Federici M., Porzio O., Lauro D., Fusco A., et al. Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential. Diabetes Metab Res Rev 16 6 (2000) 434-441
29. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16 1 (1995) 3-34
30. Naeye R.L. Pregnancy hypertension, placental evidences of low uteroplacental blood flow, and spontaneous premature delivery. Hum Pathol 20 5 (1989) 441-444
31. Banerjee K., Mohr L., Wands J.R., and de la Monte S.M. Ethanol inhibition of insulin signaling in hepatocellular carcinoma cells. Alcohol Clin Exp Res 22 9 (1998) 2093-2101
32. de la Monte S.M., Ganju N., Tanaka S., Banerjee K., Karl P.J., Brown N.V., et al. Differential effects of ethanol on insulin-signaling through the insulin receptor substrate-1. Alcohol Clin Exp Res 23 5 (1999) 770-777
33. Smith G.C., Stenhouse E.J., Crossley J.A., Aitken D.A., Cameron A.D., and Connor J.M. Early-pregnancy origins of low birth weight. Nature 417 6892 (2002) 916
34. Crossey P.A., Pillai C.C., and Miell J.P. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest 110 3 (2002) 411-418
35. Han V.K., Bassett N., Walton J., and Challis J.R. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab 81 7 (1996) 2680-2693
36. McKinnon T., Chakraborty C., Gleeson L.M., Chidiac P., and Lala P.K. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab 86 8 (2001) 3665-3674
37. Shin J.C., Lee J.H., Yang D.E., Moon H.B., Rha J.G., and Kim S.P. Expression of insulin-like growth factor-II and insulin-like growth factor binding protein-1 in the placental basal plate from pre-eclamptic pregnancies. Int J Gynaecol Obstet 81 3 (2003) 273-280
38. Pijnenborg R., Anthony J., Davey D.A., Rees A., Tiltman A., Vercruysse L., et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 98 7 (1991) 648-655